Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102219803A details a novel nitrone-based route for Ezetimibe intermediates, offering superior stereocontrol and reduced raw material consumption for pharmaceutical manufacturing.
Patent CN102093278B reveals a novel synthesis for Doripenem Intermediate I, achieving 99.5% purity and >75% yield via eco-friendly reagents and optimized coupling.
Patent CN107445950B reveals a novel oxidation-reduction refining method for tebipenem pivoxil side chain, offering high purity and yield for cost-effective manufacturing.
Advanced one-pot synthesis of Ertapenem Sodium Salt via patent CN100457760C. Delivers significant cost reduction and simplified purification for antibiotic manufacturing supply chains.
Patent CN1152570A reveals base-catalyzed isomerization for high-purity trans-oxazolidine. Delivers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel triiodo-benzene synthesis reduces osmotic pressure. Reliable pharmaceutical intermediate supplier offering cost-effective scaling.
Patent CN101348486B reveals a novel 6-step Meropenem synthesis avoiding Noble Metal Rhodium. Discover cost-effective manufacturing and supply chain advantages.
Patent CN108033906A reveals high-yield Silodosin intermediate synthesis. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN108658784A reveals a novel synthesis route for glaucoma drug intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107586268B reveals a high-yield route for Erexib intermediates using condensing agents, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN109734762B details a novel one-pot method for 16-beta-methyl steroids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Grignard-based route for steroid intermediate offers high yield and mild conditions. Scalable for pharma supply chains ensuring cost reduction and continuity.
Novel 4-step route for Sofosbuvir key intermediate. Avoids hazardous reagents. Reliable supplier for high-purity pharmaceutical intermediates.
Novel synthesis of Abiraterone Acetate via CN107176965A patent. Cost-effective route using pregnadienolone acetate for reliable pharmaceutical intermediate supply chain.
Patent CN104263803A details high-purity S-2-tetrahydronaphthalene amine synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel low-temperature method for delta 16 steroid. High yield, no heavy metals. Reliable supply for adrenal hormone manufacturing.
Patent CN104263799A enables high-purity S-2-tetrahydronaphthylamine via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN101613666B details a novel Bacillus sp. ECU0015 strain for high-purity chiral diol production, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN111675650A details a green photo-induced synthesis for aromatic vinyl bromides. Delivers cost reduction in pharmaceutical intermediate manufacturing with high purity.
Novel TEMPO-mediated route for Vitamin D3 intermediate. Cost-effective, eco-friendly manufacturing process ensuring high purity and supply reliability.